Acute hemodynamic responses to vasodilator therapy in congestive heart failure.
D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D003327:Coronary Disease / Q000503:physiopathology; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D009566:Nitrates / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D005082:Physical Exertion; D011224:Prazosin / Q000627:therapeutic use; D012084:Renin-Angiotensin System / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000806:Angiotensin-Converting Enzyme Inhibitors; D009566:Nitrates; D014665:Vasodilator Agents; D009599:Nitroprusside; D006830:Hydralazine; D011224:Prazosin; D010646:Phentolamine